Professional Documents
Culture Documents
Exhibit 1: Changes made to our earnings estimates, target prices and ratings
New New Old Old New Old New Old Chg
CMP New Old
Company Mkt cap FY20E EPS FY21E EPS FY20E EPS FY21E EPS target P/E target P/E TP TP (%)
(Rs) rating rating
(US$bn) (Rs) (Rs) (Rs) (Rs) (x) (x) (Rs) (Rs)
TCS 2,023 110 92.0 97.4 92.0 97.4 16.5 16.5 Sell Sell 1,607 1,607 0
Infosys 710 45 39.5 41.7 39.5 41.7 14.9 14.9 Sell Sell 620 603 2.8
Wipro 258 23 17.8 18.1 23.8 24.2 11.6 11.6 Sell Sell 209 277 -24
HCL Technologies 1,012 20 83.4 87.0 83.4 87.0 12.4 12.4 Acc Acc 1,076 1,054 2.1
Tech Mahindra 789 11 56.2 59.3 56.2 59.3 9.9 9.9 Sell Sell 587 561 4.6
Mindtree 963 2 54.2 56.0 54.2 56.0 9.9 9.9 Sell Sell 554 553 0.2
Persistent Systems 658 1 57.2 59.3 57.2 59.3 8.3 8.3 Sell Sell 489 481 1.7
FDEPS (Rs)
FY18 67.0 32.5 16.8 62.9 42.8 34.7 40.4
FY19E 82.9 35.7 18.5 74.4 50.1 46.2 44.2
FY20E 92.0 39.5 17.8 83.4 56.2 54.2 57.2
FY21E 97.4 41.7 18.1 87.0 59.3 56.0 59.3
PE (x)
FY18 30.2 21.9 15.3 16.1 18.4 27.8 16.3
FY19E 24.4 19.9 13.9 13.6 15.7 20.8 14.9
FY20E 22.0 18.0 14.5 12.1 14.0 17.8 11.5
FY21E 20.8 17.0 14.2 11.6 13.3 17.2 11.1
EV/EBITDA (x)
FY18 23.7 15.2 13.8 11.2 13.8 20.0 10.7
FY19E 19.1 14.4 11.2 9.2 9.8 13.9 8.7
FY20E 17.4 12.7 9.2 8.2 8.8 11.3 6.8
FY21E 16.8 12.0 8.8 7.7 8.3 10.6 6.1
EV/Sales (x)
FY18 6.2 4.1 2.6 2.5 2.1 2.7 1.7
FY19E 5.3 3.7 2.2 2.1 1.8 2.1 1.5
FY20E 4.7 3.3 1.9 1.9 1.6 1.8 1.2
FY21E 4.5 3.1 1.8 1.8 1.5 1.7 1.1
RoIC (%)
FY18 57.3 44.9 24.5 38.9 25.8 32.9 29.7
FY19E 61.7 47.9 29.2 37.3 36.3 47.6 41.4
FY20E 61.5 51.3 35.4 34.1 38.1 51.3 49.9
FY21E 61.1 50.2 35.8 30.1 38.7 53.2 53.5
Source: Bloomberg, Nirmal Bang Institutional Equities Research
CNX BANK (8.7) 63.9 (9.3) 6.6 41.4 6.4 18.9 8.2 3.6 6.0 (4.8) 8.7 (4.7) 8.0 9.1
CNX IT 57.2 17.4 (0.3) (7.4) 11.7 25.1 4.0 (5.1) 3.2 9.7 8.8 11.8 13.2 (9.2) 6.8
CNX FMCG 11.7 17.8 0.1 1.7 30.5 14.8 15.4 13.6 (8.5) 8.7 (1.8) 10.9 2.7 2.6 (1.2)
CNX AUTO 9.9 57.3 (0.7) 10.5 30.2 (22.2) 8.5 6.7 2.6 9.7 (8.7) (1.0) (10.4) (3.8) (6.5)
CNX ENERGY 0.1 8.4 (0.7) 19.2 40.8 0.6 14.8 (0.4) 10.1 11.9 (7.5) 0.9 17.7 (8.5) 13.7
CNX PHARMA 26.3 42.6 10.3 (15.5) (5.4) (8.0) 2.8 (7.7) (4.5) 4.5 (12.8) 9.8 8.7 (11.6) 4.4
CNX METAL (13.8) 6.2 (31.3) 45.5 49.7 (21.4) 17.1 (3.4) 18.7 11.5 (11.3) (2.1) 1.3 (10.7) (2.7)
CNX INFRA (4.7) 22.5 (8.8) (2.3) 34.1 (11.8) 15.2 3.4 1.4 11.1 (7.7) (6.1) (5.1) 7.1 (0.4)
CNX MIDCAP (5.4) 55.7 7.2 6.5 47.4 (15.2) 20.8 3.1 2.1 15.9 (10.6) (3.1) (5.6) 3.7 0.1
CNX SMALLCAP (8.1) 53.9 7.4 2.2 57.5 (29.0) 22.1 4.7 3.7 18.8 (13.6) (7.9) (14.3) 4.0 2.3
NIFTY 6.5 31.1 (4.3) 2.6 29.3 3.6 13.2 3.8 2.8 7.0 (3.5) 5.9 2.0 (0.6) 5.5
USD/INR 61.8 63.0 66.2 67.4 65.1 68.5 67.0 64.5 `64.3 64.7 65.2 68.5 70.1 72.1 70.7
Source: Bloomberg, Nirmal Bang Institutional Equities Research
Other income (net) 958 1,190 725 1,173 1,472 Opening cash 1,432 1,510 2,414 342 3,636
PBT 4,007 4,292 4,927 6,222 6,449 Closing cash 1,510 2,414 342 3,636 8,395
-PBT margin (%) 13.9 14.1 14.5 15.8 16.3 Change in cash 77 904 (2,072) 3,294 4,759
Provision for tax 992 1,062 1,422 1,816 1,882 Source: Company, Nirmal Bang Institutional Equities Research
Effective tax rate (%) 24.8 24.7 28.9 29.2 29.2
Exhibit 32: Key ratios
Net profit 3,015 3,231 3,505 4,406 4,567
-Growth (%) 1.4 7.2 8.5 25.7 3.6 Y/E March FY17 FY18 FY19E FY20E FY21E
-Net profit margin (%) 10.5 10.6 10.3 11.2 11.5 Per Share (Rs)
Source: Company, Nirmal Bang Institutional Equities Research EPS 37.7 40.4 44.2 57.2 59.3
FDEPS 37.7 40.4 44.2 57.2 59.3
Exhibit 31: Balance sheet Dividend Per Share 9.0 10.0 10.2 14.1 13.6
Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Book Value 237 266 279 319 362
Equity capital 800 800 770 770 770 Dividend Payout Ratio (%) 25 25 27 30 28
Reserves & surplus 18,193 20,472 20,709 23,810 27,118 Return ratios (%)
Net worth 18,993 21,272 21,479 24,580 27,888 RoE 17.2 15.4 19.7 21.9 19.0
Deferred tax liability 111 - 316 316 316 RoCE 17.1 15.3 19.5 21.6 18.7
Other liabilities 166 160 168 168 168 Pre Tax ROIC 31.1 29.7 41.4 49.9 53.5
Total loans 22 17 13 13 13 Tunover Ratios
Total liabilities 19,291 21,448 21,977 25,078 28,386 Asset Turnover Ratio 1.5 1.4 1.6 1.6 1.4
Goodwill 76 77 82 82 82 Debtor Days (incl. unbilled Rev) 60 58 56 58 54
Net block (incl CWIP) 5,573 5,097 4,357 3,266 2,131 Working Capital Cycle Days 39 51 51 50 52
Investments 6,839 8,797 11,252 11,252 11,252 Valuation ratios (x)
Deferred tax asset 306 372 720 720 720 PER 17.5 16.3 14.9 11.5 11.1
Other non-current assets 994 129 277 277 277 P/BV 2.8 2.5 2.4 2.1 1.8
Other current assets 3,411 4,585 5,381 6,360 6,016 EV/EBTDA 11.3 10.7 8.7 6.8 6.1
Debtors 4,754 4,847 5,211 6,191 5,846 EV/Sales 1.8 1.7 1.5 1.2 1.1
Cash & bank balance 1,510 2,414 342 3,636 8,395 M-cap/Sales 1.8 1.7 1.5 1.3 1.3
Total current assets 9,675 11,846 10,934 16,187 20,257 Dividend Yield 1.4 1.5 1.6 2.1 2.1
Total current liabilities 4,173 4,870 5,645 6,707 6,333
Source: Company, Nirmal Bang Institutional Equities Research
Net current assets 5,502 6,976 5,288 9,480 13,923
Total assets 19,291 21,448 21,977 25,078 28,386
Source: Company, Nirmal Bang Institutional Equities Research
This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as “NBEPL”) for private circulation. NBEPL is a
registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001436. NBEPL is also
a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments.
NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have
different or contrary views on stocks and markets.
NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in
securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or
its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the
subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject
company at the end of the month immediately preceding the date of publication of this research report.
NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the
company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other
benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an
officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject
company.
Analyst Certification: I, Girish Pai, research analyst and the author of this report, hereby certify that the views expressed in this
research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also
certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific
recommendations or views in this research. The analyst is principally responsible for the preparation of this research report and has
taken reasonable care to achieve and maintain independence and objectivity in making any recommendations.
Dealing
Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 8230, +91 22 6636 8833
Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 8100/8101, +91 22 6636 8831
Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 8102/8103, +91 22 6636 8830